Virosome-Formulated Plasmodium falciparum AMA-1 & CSP Derived Peptides as Malaria Vaccine: Randomized Phase 1b Trial in Semi-Immune Adults & Children

BACKGROUND: This trial was conducted to evaluate the safety and immunogenicity of two virosome formulated malaria peptidomimetics derived from Plasmodium falciparum AMA-1 and CSP in malaria semi-immune adults and children. METHODS: The design was a prospective randomized, double-blind, controlled, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cech, Patrick Georges, Aebi, Thomas, Abdallah, Mwanajaa Shomari, Mpina, Maxmillian, Machunda, Ester Barnabas, Westerfeld, Nicole, Stoffel, Sabine Alexandra, Zurbriggen, Rinaldo, Pluschke, Gerd, Tanner, Marcel, Daubenberger, Claudia, Genton, Blaise, Abdulla, Salim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142124/
https://www.ncbi.nlm.nih.gov/pubmed/21799810
http://dx.doi.org/10.1371/journal.pone.0022273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142124/
https://www.ncbi.nlm.nih.gov/pubmed/21799810
http://dx.doi.org/10.1371/journal.pone.0022273

Ejemplares similares